Company / Cash & Equivalents
Cronos Group Inc. Cash & Equivalents History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$791.8M
FY2025
5-year range
$669.3M / $887.0M
FY2021-FY2025
Trend
-7.8%
vs FY2024
Sector context
#24 of 207
Health Care
What the data says
Cronos Group Inc.'s cash & equivalents of $792M is higher than 88% of companies in the Health Care sector (FY2025). Improved from $669M to $792M over the past 2 years.
Based on SEC 10-K filings.
$792M in FY2025 with a 5-year CAGR of -6.0%. Top quartile in the Health Care sector.
Improved from $669M to $792M over the past 2 years.
Health Care sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +1.2%
- 5-Year CAGR
- -6.0%
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 207This company $791.8M Sector average $669.5M
▼
+18.3% above sector average
Key checks
Key Insights
- 5-year CAGR of -6.0%, indicating a declining trend.
- In FY2025, cash & equivalents decreased 7.8% year-over-year.
- Ranks #24 out of 207 companies in the Health Care sector.
- Peak cash & equivalents was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 5.38 (safe zone, above 2.9 threshold)
- Strong profit margin: 34.9%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $791.8M | -7.8% |
| FY2024 | $858.8M | +28.3% |
| FY2023 | $669.3M | -12.5% |
| FY2022 | $764.6M | -13.8% |
| FY2021 | $887.0M | -17.7% |
| FY2020 | $1.1B | -10.1% |
| FY2019 | $1.2B | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026